ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

APGE Apogee Therapeutics Inc

53.22
0.00 (0.00%)
12 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Apogee Therapeutics Inc APGE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 53.22 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
53.22
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/5/202407:00GLOBEApogee Therapeutics to Participate at the 2024 Bank of..
25/3/202406:00GLOBEApogee Therapeutics Announces First Participants Dosed in..
12/3/202415:01GLOBEApogee Therapeutics, Inc. Announces Closing of Upsized..
11/3/202405:01EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
07/3/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
07/3/202417:49GLOBEApogee Therapeutics, Inc. Announces Pricing of Upsized $420..
07/3/202417:27EDGAR2Form S-1MEF - Registration adding securities to prior Form..
05/3/202415:23GLOBEApogee Therapeutics, Inc. Announces Proposed..
05/3/202415:05EDGAR2Form S-1 - General form for registration of securities under..
05/3/202407:15EDGAR2Form 8-K - Current report
05/3/202405:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202405:11EDGAR2Form 8-K - Current report
05/3/202405:10GLOBEApogee Therapeutics Provides Pipeline Progress and Reports..
05/3/202405:00GLOBEApogee Announces Positive Interim Results from Phase 1..
04/3/202415:01GLOBEApogee to Host Conference Call and Webcast to Report Interim..
02/1/202406:30GLOBEApogee Therapeutics to Present at the 42nd Annual J.P...
20/12/202319:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202306:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202306:41EDGAR2Form 8-K - Current report
13/11/202306:30GLOBEApogee Highlights Corporate Progress and Reports Third..
30/10/202307:00GLOBEApogee Therapeutics to Participate in Upcoming November..
27/9/202307:42GLOBEApogee Announces Two Abstracts Accepted for Presentation at..
14/9/202306:30GLOBEApogee Therapeutics to Participate at the 2023 Stifel..
29/8/202307:00PRNUSParagon Therapeutics Recognizes Key Milestones and..
28/8/202306:30GLOBEApogee Highlights Corporate Progress and Reports Second..
21/8/202306:30GLOBEApogee Therapeutics Appoints Mark C. McKenna, Healthcare..
07/8/202306:30GLOBEApogee Announces First Participants Dosed Ahead of Schedule..
02/8/202306:30GLOBEApogee Therapeutics to Participate in Upcoming August..
18/7/202315:01GLOBEApogee Therapeutics, Inc. Announces Closing of Upsized..

Su Consulta Reciente

Delayed Upgrade Clock